Sertraline and psychotic symptoms: A case series

Annals of Clinical Psychiatry

Volumn 9, Issue 1, 1997, Pages 15-17

  Popli, Anand P ^a,b,c   Fuller, Matthew A ^a,b   Jaskiw, George E ^a,b  

^a CASE WESTERN RESERVE UNIVERSITY   (United States)

^b LOUIS STOKES CLEVELAND VA MEDICAL CENTER   (United States)

^c Porter Starke Counseling Centers   (United States)

Author keywords

Adverse drug reactions; Psychotic symptoms; Sertraline

Indexed keywords

AMFEBUTAMONE; ANTIDEPRESSANT AGENT; FLUOXETINE; HALOPERIDOL; LITHIUM CARBONATE; LORAZEPAM; LOXAPINE; MONOAMINE OXIDASE INHIBITOR; NEUROLEPTIC AGENT; NORTRIPTYLINE; PERPHENAZINE; PROPRANOLOL; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; TRICYCLIC ANTIDEPRESSANT AGENT; TRIHEXYPHENIDYL;

ADULT; AGED; ARTICLE; CASE REPORT; CONCENTRATION LOSS; DELUSION; DEPRESSION; DIARRHEA; DOSE TIME EFFECT RELATION; DRUG INTERACTION; DRUG SAFETY; DYSPEPSIA; HALLUCINATION; HUMAN; INSOMNIA; IRRITABILITY; MALE; NAUSEA; PARANOIA; PRIORITY JOURNAL; PSYCHOSIS; RESTLESSNESS; RETROSPECTIVE STUDY; RISK FACTOR; SEXUAL DYSFUNCTION; SOMNOLENCE; SPEECH DISORDER; SWEATING; TREMOR; VERTIGO; XEROSTOMIA;

1-NAPHTHYLAMINE; ADULT; AGED; HUMANS; MALE; MENTAL DISORDERS; MIDDLE AGED; PSYCHOSES, SUBSTANCE-INDUCED; SEROTONIN UPTAKE INHIBITORS; SERTRALINE;

EID: 0030752783     PISSN: 10401237     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1026274123689     Document Type: Article

References (15)

1. Naranjo CA, Busto U, Sellers EM, Sandor EM, Ruiz I, Roberts EA, Janecek E, Domecq C, Greenblatt DJ: A method for estimating the probability of adverse reactions. Clin Pharmacol Ther 1991; 30:239-245
2. Wehr TA, Goodwin FK: Can antidepressants cause mania and worsen the course of affective illness? Am J Psychiatry 1987; 144(1);403-411
3. Bunney WE Jr: Psychopharmacology of the switch process in affective illness. In: Lipton MA, DiMascio A, Kellem KF, eds. Psychopharmacology: A Generation of Progress. New York: Raven Press; 1978
4. Keshavan MS, Keshavan A: Drug-induced psychotic disorders. In: Keshavan MS, Kennedy JS, eds. Drug-Induced Dysfunction in Psychiatry. New York: Hemisphere; 1992
5. Nelson JC, Bowers MB, Sweeney DR: Exacerbation of psychosis by tricyclic antidepressants in delusional depression. Am J Psychiatry 1979; 136:574-576
6. Stoll AL, Mayer PV, Kolbrener M, Goldstein E, Suplit B, Lucier J, Cohen BM, Tohen M: Antidepressant-associated mania: A controlled comparison with spontaneous mania. Am J Psychiatry 1994; 151:1642-1645
7. Pach J: Pharmacotoxic psychosis and extrapyramidal motor syndrome. A case of acute adverse effect of fluoxetine and flupenthixol. Nervenarzt 1992; 63:575-576 (in German)
8. Hersch CB, Sokol MS, Pfeffer CR: Transient psychosis with fluoxetine. J Am Acad Child Adol Psychiatry 1991; 30:851-852 (letter)
9. Lauterbach EC: Serotonin reuptake inhibitors, paranoia, and the ventral basal ganglia. Clin Neuropharmacol 1991; 14:547-555
10. Mandalos GE, Szarek BL: dose related paranoid reaction associated with fluoxetine. J Nerv Ment Dis 1990; 178:57-58
11. Markel H, Lee A, Holmes RD, Domino EF: LSD flashback syndrome exacerbated by selective serotonin reuptake inhibitor antidepressants in adolescents. J Pediatr 1994; 125:817-819
12. Koe BK, Weisman A, Welch WM, Brown RG: Sertraline, 1S, 4S-N-methyl-4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-1-naph thyline, a new uptake inhibitor with selectivity for serotonin. J Pharmacol Exp Ther 1983; 230:94-102
13. Matthysse S: Dopamine and the pharmacology of schizophrenia: The state of the evidence. J Psychiatr Res 1974; 11:107-113
14. Hornykiewicz O: Psychopharmacological implications of dopamine and dopamine antagonists: A critical evaluation of current evidence. Neuroscience 1978; 3:773-783
15. Goff DC, Brotman AW, Waites M, McCormick S: Trial of fluoxetine added to neuroleptics for treatment-resistant schizophrenic patients. Am J Psychiatry 1990; 147:492-494